$12.32 Billion in Sales Expected for HCA Healthcare Inc (HCA) This Quarter

Wall Street analysts expect that HCA Healthcare Inc (NYSE:HCA) will announce sales of $12.32 billion for the current fiscal quarter, Zacks Investment Research reports. Eleven analysts have provided estimates for HCA Healthcare’s earnings. The lowest sales estimate is $12.21 billion and the highest is $12.43 billion. HCA Healthcare reported sales of $11.42 billion during the same quarter last year, which would suggest a positive year over year growth rate of 7.9%. The business is scheduled to report its next earnings report on Tuesday, May 7th.

On average, analysts expect that HCA Healthcare will report full year sales of $50.78 billion for the current fiscal year, with estimates ranging from $50.63 billion to $51.03 billion. For the next financial year, analysts forecast that the firm will report sales of $53.51 billion, with estimates ranging from $52.35 billion to $55.88 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research firms that that provide coverage for HCA Healthcare.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, January 29th. The company reported $2.99 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.59 by $0.40. The company had revenue of $12.27 billion for the quarter, compared to analysts’ expectations of $12.10 billion. HCA Healthcare had a negative return on equity of 91.25% and a net margin of 8.11%. The firm’s revenue was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.12 earnings per share.

Several research analysts have issued reports on the company. ValuEngine cut HCA Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, March 6th. Oppenheimer upped their price target on HCA Healthcare from $142.00 to $150.00 and gave the company an “outperform” rating in a report on Wednesday, January 30th. SunTrust Banks upped their price target on HCA Healthcare to $175.00 and gave the company a “buy” rating in a report on Wednesday, January 30th. Leerink Swann upped their price target on HCA Healthcare from $160.00 to $175.00 and gave the company an “outperform” rating in a report on Wednesday, January 30th. Finally, Stephens assumed coverage on HCA Healthcare in a report on Monday, January 14th. They issued an “overweight” rating and a $143.00 price target on the stock. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and seventeen have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $148.43.

Shares of NYSE HCA traded up $2.99 during trading on Thursday, hitting $128.88. The company had a trading volume of 2,694,974 shares, compared to its average volume of 1,692,421. The stock has a market capitalization of $43.14 billion, a P/E ratio of 13.19, a P/E/G ratio of 1.20 and a beta of 0.80. HCA Healthcare has a 52 week low of $93.03 and a 52 week high of $147.42.

The company also recently announced a quarterly dividend, which will be paid on Friday, March 29th. Shareholders of record on Friday, March 1st will be paid a dividend of $0.40 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.35. This represents a $1.60 annualized dividend and a yield of 1.24%. The ex-dividend date is Thursday, February 28th. HCA Healthcare’s payout ratio is 14.33%.

In other news, insider Jon M. Foster sold 11,640 shares of the company’s stock in a transaction on Tuesday, February 12th. The shares were sold at an average price of $139.68, for a total value of $1,625,875.20. Following the transaction, the insider now directly owns 84,492 shares of the company’s stock, valued at $11,801,842.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Bill B. Rutherford sold 37,500 shares of the company’s stock in a transaction on Tuesday, February 12th. The stock was sold at an average price of $139.65, for a total transaction of $5,236,875.00. Following the completion of the transaction, the chief financial officer now directly owns 58,972 shares in the company, valued at $8,235,439.80. The disclosure for this sale can be found here. Insiders sold 78,476 shares of company stock worth $10,940,008 over the last ninety days. 2.80% of the stock is currently owned by company insiders.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Benjamin F. Edwards & Company Inc. acquired a new position in shares of HCA Healthcare in the fourth quarter worth $25,000. Sontag Advisory LLC bought a new stake in HCA Healthcare in the fourth quarter worth $26,000. Moody National Bank Trust Division bought a new stake in HCA Healthcare in the fourth quarter worth $27,000. Doyle Wealth Management bought a new stake in HCA Healthcare in the fourth quarter worth $31,000. Finally, Trust Co. of Vermont boosted its holdings in HCA Healthcare by 165.3% in the fourth quarter. Trust Co. of Vermont now owns 329 shares of the company’s stock worth $41,000 after purchasing an additional 205 shares in the last quarter. 70.63% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Read More: Different Types of Derivatives

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.